TY - JOUR
KW - Substance Use Disorders -- Drug Therapy
KW - Hospital Programs
KW - Naltrexone -- Therapeutic Use
KW - Buprenorphine -- Therapeutic Use
KW - Outcomes (Health Care)
KW - Human
KW - Descriptive Statistics
KW - Male
KW - Female
AU - Sarah E. Wakeman
AU - Martha Kane
AU - Elizabeth Powell
AU - Sydney Howard
AU - Christopher Shaw
AU - Laura Kehoe
AU - Joy Rosen
AU - Joan Quinlan
AU - Susan Regan
A1 - 
AD - Department of Medicine, Massachusetts General Hospital, Boston, MA, USA; Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA; Department of Nursing and Patient Care Services, Massachusetts General Hospital, Boston, MA, USA; Center for Community Health Improvement, Massachusetts General Hospital, Boston, MA, USA
BT - Substance Abuse
C5 - Education & Workforce; Healthcare Disparities; Opioids & Substance Use
CP - 4
CY - Philadelphia, Pennsylvania
DO - 10.1080/08897077.2020.1846664
IS - 4
JF - Substance Abuse
LA - English
M1 - Journal Article
PB - Taylor & Francis Ltd
PP - Philadelphia, Pennsylvania
PY - 2021
SN - 0889-7077
SP - 767
EP - 774
EP - 
T1 - A hospital-wide initiative to redesign substance use disorder care: Impact on pharmacotherapy initiation
T2 - Substance Abuse
TI - A hospital-wide initiative to redesign substance use disorder care: Impact on pharmacotherapy initiation
U1 - Education & Workforce; Healthcare Disparities; Opioids & Substance Use
U3 - 10.1080/08897077.2020.1846664
UR - https://search.ebscohost.com/login.aspx?direct=true&db=cin20&AN=154101841&site=ehost-live
VL - 42
VO - 0889-7077
Y1 - 2021
Y2 - 10
ER -